216 related articles for article (PubMed ID: 12094300)
1. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
[TBL] [Abstract][Full Text] [Related]
2. [Vancomycin resistant enterococci].
Fujita N; Komori T; Ike Y; Yoshimura M
Rinsho Byori; 1998 Jul; 46(7):629-36. PubMed ID: 9721528
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections.
Busani L; Del Grosso M; Paladini C; Graziani C; Pantosti A; Biavasco F; Caprioli A
Int J Food Microbiol; 2004 Dec; 97(1):17-22. PubMed ID: 15527914
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Iinuma M; Piyasena KG; Dharmaratne HR
Phytomedicine; 2005 Mar; 12(3):203-8. PubMed ID: 15830842
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of isoprenoid-substituted xanthones from Cudrania cochinchinensis against vancomycin-resistant enterococci.
Fukai T; Oku Y; Hou AJ; Yonekawa M; Terada S
Phytomedicine; 2005 Jun; 12(6-7):510-3. PubMed ID: 16008130
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
8. [Vancomycin resistant enterococci in the Netherlands].
Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
[TBL] [Abstract][Full Text] [Related]
9. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
Kolár M; Vágnerová I; Látal T; Kohnová I
Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
[TBL] [Abstract][Full Text] [Related]
12. New and antifungal xanthones from Calophyllum caledonicum.
Morel C; Séraphin D; Teyrouz A; Larcher G; Bouchara JP; Litaudon M; Richomme P; Bruneton J
Planta Med; 2002 Jan; 68(1):41-4. PubMed ID: 11842325
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
Palombo EA; Semple SJ
J Basic Microbiol; 2002; 42(6):444-8. PubMed ID: 12442307
[TBL] [Abstract][Full Text] [Related]
15. [Molecular characterization of vancomycin-resistant enterococci isolates].
Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant Enterococcus faecium in vitro.
Rahbar M; Mehrgan H; Hadji-nejad S
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):676-9. PubMed ID: 20353486
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycin-resistant enterococci.
Kim JB; Lee GS; Kim YB; Kim SK; Kim YH
Int J Antimicrob Agents; 2004 Dec; 24(6):613-5. PubMed ID: 15555887
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant enterococci in Brooklyn, New York: a moment in time.
Landman D; Volkert F; Manikal V; Saurina G; Ruan Y; Oydna E; Parola C; Quale J
Clin Infect Dis; 1999 Dec; 29(6):1587-8. PubMed ID: 10585828
[No Abstract] [Full Text] [Related]
19. Emerging vancomycin resistance in enterococci in India.
Ghoshal U; Garg A; Tiwari DP; Ayyagari A
Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activities of disinfectants against vancomycin-resistant enterococci.
Sakagami Y; Kajimura K
J Hosp Infect; 2002 Feb; 50(2):140-4. PubMed ID: 11846542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
